Yasushi Kataoka Selected Research

Yasushi Kataoka Research Topics

Disease

13	Neoplasms (Cancer) 09/2014 - 01/2002
5	Sarcoma (Soft Tissue Sarcoma) 05/2008 - 01/2002
4	Cataract (Cataracts) 09/2015 - 01/2003
3	Neoplasm Metastasis (Metastasis) 08/2009 - 01/2002
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2019
2	Glioma (Gliomas) 05/2002 - 01/2002
1	Mastitis 07/2022
1	Clostridium Infections 01/2021
1	Bovine Mastitis 04/2020
1	Retinal Perforations 03/2019
1	Hemorrhagic Septicemia (Haemorrhagic Septicemia) 01/2018
1	Macular Degeneration (Age-Related Maculopathy) 01/2017
1	Refractive Errors (Refractive Error) 09/2015
1	Carcinoma (Carcinomatosis) 01/2011
1	Wounds and Injuries (Trauma) 09/2009
1	Neutropenia 08/2009
1	Rectal Neoplasms (Rectal Cancer) 08/2009
1	Cholera 05/2008
1	Colorectal Neoplasms (Colorectal Cancer) 04/2007
1	Capsule Opacification 04/2006
1	Hypoxia (Hypoxemia) 10/2004
1	Glioblastoma (Glioblastoma Multiforme) 03/2004
1	Endophthalmitis (Ophthalmia) 01/2003
1	Xerostomia 05/2002
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2002
1	Anemia 01/2002

Drug/Important Bio-Agent (IBA)

11	Amifostine (Ethyol)FDA LinkGeneric 03/2009 - 01/2002
8	N-(2-mercaptoethyl)-1,3-diaminopropaneIBA 01/2011 - 01/2002
5	Sulfhydryl Compounds (Thiols)IBA 05/2008 - 01/2002
3	Pharmaceutical PreparationsIBA 05/2008 - 02/2002
2	Capsules (Microcapsules)IBA 09/2015 - 04/2006
2	SiliconesIBA 06/2009 - 01/2003
2	AntioxidantsIBA 03/2009 - 05/2002
2	Superoxide DismutaseIBA 03/2009 - 01/2002
2	Proteins (Proteins, Gene)FDA Link 05/2008 - 01/2002
2	AngiostatinsIBA 12/2002 - 01/2002
2	Transcription Factors (Transcription Factor)IBA 05/2002 - 01/2002
1	Cefazolin (Ancef)FDA LinkGeneric 07/2022
1	First Generation CephalosporinsIBA 04/2020
1	Cephapirin (Cefapirin)FDA Link 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2020
1	AntibodiesIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Ranibizumab (Lucentis)FDA Link 01/2017
1	CarcinogensIBA 09/2014
1	S(8)IBA 09/2009
1	Hemoglobins (Hemoglobin)IBA 08/2009
1	PlatinumIBA 08/2009
1	Glutathione PeroxidaseIBA 03/2009
1	CatalaseIBA 03/2009
1	VaccinesIBA 05/2008
1	Captopril (Capoten)FDA LinkGeneric 11/2004
1	NF-KappaB Inhibitor alphaIBA 11/2004
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 11/2004
1	superoxide dismutase 2IBA 11/2004
1	Mesna (Coenzyme M)FDA LinkGeneric 11/2004
1	Free RadicalsIBA 10/2004
1	HydrogenIBA 10/2004
1	DNA (Deoxyribonucleic Acid)IBA 03/2004
1	Matrix Metalloproteinases (MMPs)IBA 01/2002
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2002
1	E-SelectinIBA 01/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2002
1	Epoetin Alfa (Epogen)FDA Link 01/2002
1	Interleukin-8 (Interleukin 8)IBA 01/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2002
1	InterleukinsIBA 01/2002
1	Interleukin-6 (Interleukin 6)IBA 01/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2002
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2002
1	P-SelectinIBA 01/2002

Therapy/Procedure

6	Therapeutics 07/2022 - 02/2002
4	Intraocular Lenses (Intraocular Lens) 09/2015 - 01/2003
3	Radiotherapy 03/2009 - 01/2002
2	Fecal Microbiota Transplantation 01/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 08/2009 - 10/2004
2	Surgical Amputation (Amputations) 12/2002 - 01/2002
1	Traction 03/2019
1	Renal Dialysis (Hemodialysis) 08/2009
1	Aftercare (After-Treatment) 01/2002